the Company and its subsidiary for the three-month period ended 31 March 2018, which have been reviewed by the company’s authorized auditor. The company would like to clarify the operating results of
Interim Financial Statements the three-month and the six-month period ended 30 June 2018, which have been reviewed by the Company’s authorized auditor. The company would like to clarify the operating
decrease by 75.88 million Baht or 2.47% compared to same period of 2017) due to the declining in raw water sales volume and net profit attributable to Equity holders of the parent company was 881.03 million
42.4% 672.4 36.0% 98.0 17.1% Gross Profit 781.9 57.6% 1,086.3 58.1% 304.4 38.9% Other Revenues 5.4 0.4% 17.2 0.9% 11.8 217.8% Administrative Expenses 211 15.6% 302.8 16.2% 91.8 43.5% Operating Profit
generated revenues of THB 1,801. 0 million from the sales and services, which is decreased from the same quarter of the previous year in the amount of THB 36. 4 million or equivalent to an decrease of 2. 0
the decrease was due to hotel operations in the United Arab Emirates, but increased in performance in Guam. Income from education business was THB 76 million, decreased by 7% Education Business The
Australia to EGR Europe as delivery country. Gross profit margin decreased 4% duted to sold OEM project that high gross profit margin decrease, gross profit of Trading products decreased dued to Baht strength
. On 3 April 2017, the Annual General Meeting of the Company’s shareholders passed resolution approved a decrease in the Company’s registered capital from Baht 664,892,534 to Baht 474,917,334 by
President The Stock Exchange of Thailand Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the 2nd quarter of 2018